Eva Harris Selected Research

Flavivirus Infections

1/2022	Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis.
1/2021	Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
1/2021	Levels of Circulating NS1 Impact West Nile Virus Spread to the Brain.
1/2018	ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
1/2018	Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
12/2002	Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva Harris Research Topics

Disease

105	Infections 01/2022 - 12/2002
76	Dengue (Dengue Fever) 05/2022 - 12/2002
27	Zika Virus Infection 01/2022 - 08/2016
18	Severe Dengue 01/2022 - 09/2007
10	Virus Diseases (Viral Diseases) 01/2022 - 12/2002
8	Fever (Fevers) 01/2020 - 07/2009
6	Flavivirus Infections 01/2022 - 12/2002
5	Human Influenza (Influenza) 05/2022 - 11/2009
5	Yellow Fever 05/2022 - 03/2006
5	COVID-19 01/2022 - 01/2021
5	Shock 01/2022 - 08/2009
4	Coinfection 05/2017 - 09/2010
3	Japanese Encephalitis 05/2022 - 01/2018
3	Microcephaly 01/2021 - 11/2017
2	Leukopenia 01/2020 - 01/2012
2	Arthralgia (Joint Pain) 01/2020 - 01/2012
2	Vomiting 01/2020 - 01/2012
2	Exanthema (Rash) 01/2020 - 01/2012
2	Myalgia 01/2020 - 01/2012
2	Headache (Headaches) 01/2020 - 01/2012
2	Pain (Aches) 01/2020 - 01/2012
2	Guillain-Barre Syndrome 01/2019 - 01/2018
2	Hemorrhage 06/2017 - 01/2015
2	Mosquito-Borne Diseases 06/2013 - 12/2002
1	Inflammation (Inflammations) 01/2022
1	Congenital Abnormalities (Deformity) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Atherosclerosis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Rickettsia Infections 01/2021
1	Sepsis (Septicemia) 01/2021
1	Nausea 01/2020
1	Respiratory Sounds (Crackle) 01/2020
1	Cyanosis 01/2020
1	Apnea 01/2020
1	Respiratory Syncytial Virus Infections 01/2020
1	Arbovirus Infections 01/2019
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2018

Drug/Important Bio-Agent (IBA)

43	AntibodiesIBA 01/2022 - 03/2003
37	VaccinesIBA 01/2022 - 07/2009
27	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2005
15	Immunoglobulin M (IgM)IBA 01/2021 - 03/2003
15	Neutralizing AntibodiesIBA 01/2020 - 01/2011
14	Immunoglobulin G (IgG)IBA 01/2022 - 02/2004
12	EnzymesIBA 01/2022 - 07/2005
12	Antiviral Agents (Antivirals)IBA 10/2021 - 12/2002
11	ImmunosorbentsIBA 01/2022 - 07/2005
10	Dengue VaccinesIBA 01/2022 - 01/2013
10	AntigensIBA 01/2021 - 08/2004
10	EpitopesIBA 01/2021 - 09/2010
10	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2002
9	InterferonsIBA 06/2016 - 03/2004
8	CytokinesIBA 01/2020 - 06/2005
8	Monoclonal AntibodiesIBA 08/2017 - 02/2010
7	Immune Sera (Antisera)IBA 01/2022 - 01/2013
7	Peptides (Polypeptides)IBA 01/2018 - 08/2004
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 06/2007
5	Blocking AntibodiesIBA 10/2021 - 02/2013
5	Viral RNAIBA 01/2021 - 12/2002
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
3	Interferon Receptors (Interferon Receptor)IBA 01/2021 - 10/2006
3	Glycoproteins (Glycoprotein)IBA 01/2020 - 10/2008
3	Attenuated VaccinesIBA 01/2020 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 09/2009
3	Explosive Agents (Explosives)IBA 01/2018 - 11/2017
3	Indicators and Reagents (Reagents)IBA 09/2007 - 07/2005
2	oxidized low density lipoproteinIBA 01/2022 - 01/2015
2	IgYIBA 11/2020 - 07/2017
2	Broadly Neutralizing AntibodiesIBA 01/2020 - 05/2017
2	Immunologic Factors (Immunomodulators)IBA 01/2019 - 03/2004
2	Combined VaccinesIBA 01/2018 - 01/2012
2	Biological ProductsIBA 01/2018 - 07/2009
2	PesticidesIBA 01/2017 - 01/2017
2	GlucosidasesIBA 05/2016 - 03/2016
2	Nucleic AcidsIBA 06/2014 - 06/2010
2	Interferon-betaIBA 10/2012 - 03/2004
2	Immunoglobulin A (IgA)IBA 11/2008 - 03/2003
2	Interleukin-10 (Interleukin 10)IBA 10/2008 - 06/2005
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2022
1	cadherin 5IBA 05/2022
1	CateninsIBA 05/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	GlucansIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	PlasticsIBA 01/2022
1	SyndecansIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	ChemokinesIBA 01/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	antineoplaston A10 (A 10)IBA 11/2018
1	ProteomeIBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	TeratogensIBA 01/2018

Therapy/Procedure

14	Therapeutics 12/2021 - 12/2002
2	Tourniquets 01/2020 - 01/2012